PortfoliosLab logo
AVTE vs. IMRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AVTE and IMRX is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

AVTE vs. IMRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aerovate Therapeutics, Inc. (AVTE) and Immuneering Corporation (IMRX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

AVTE:

$77.68M

IMRX:

$61.00M

EPS

AVTE:

-$59.50

IMRX:

-$1.97

PS Ratio

AVTE:

0.00

IMRX:

563.62

PB Ratio

AVTE:

35.57

IMRX:

1.46

Total Revenue (TTM)

AVTE:

$0.00

IMRX:

$726.33K

Gross Profit (TTM)

AVTE:

-$28.00K

IMRX:

$187.68K

EBITDA (TTM)

AVTE:

-$53.11M

IMRX:

-$15.53B

Returns By Period


AVTE

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

IMRX

YTD

-22.27%

1M

43.70%

6M

-18.18%

1Y

23.91%

3Y*

-27.46%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aerovate Therapeutics, Inc.

Immuneering Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

AVTE vs. IMRX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVTE
The Risk-Adjusted Performance Rank of AVTE is 1919
Overall Rank
The Sharpe Ratio Rank of AVTE is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of AVTE is 3232
Sortino Ratio Rank
The Omega Ratio Rank of AVTE is 2828
Omega Ratio Rank
The Calmar Ratio Rank of AVTE is 22
Calmar Ratio Rank
The Martin Ratio Rank of AVTE is 2525
Martin Ratio Rank

IMRX
The Risk-Adjusted Performance Rank of IMRX is 6262
Overall Rank
The Sharpe Ratio Rank of IMRX is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of IMRX is 7070
Sortino Ratio Rank
The Omega Ratio Rank of IMRX is 6666
Omega Ratio Rank
The Calmar Ratio Rank of IMRX is 6060
Calmar Ratio Rank
The Martin Ratio Rank of IMRX is 5757
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AVTE vs. IMRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Aerovate Therapeutics, Inc. (AVTE) and Immuneering Corporation (IMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

AVTE vs. IMRX - Dividend Comparison

Neither AVTE nor IMRX has paid dividends to shareholders.


Drawdowns

AVTE vs. IMRX - Drawdown Comparison


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

AVTE vs. IMRX - Volatility Comparison


Loading data...

Financials

AVTE vs. IMRX - Financials Comparison

This section allows you to compare key financial metrics between Aerovate Therapeutics, Inc. and Immuneering Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-100.00M-50.00M0.0050.00M100.00M2021202220232024202500
(AVTE) Total Revenue
(IMRX) Total Revenue
Values in USD except per share items